Farmaceutica REMEDIA S.A. (BVB:RMAH)
Romania
· Delayed Price · Currency is RON 0.6980
+0.0080 (1.16%)
At close: Jun 6, 2025
Farmaceutica REMEDIA Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 760.21 | 743.79 | 593.36 | 535.85 | 477.1 | 441.48 | Upgrade
|
| Revenue | 760.21 | 743.79 | 593.36 | 535.85 | 477.1 | 441.48 | Upgrade
|
| Revenue Growth (YoY) | 20.72% | 25.35% | 10.73% | 12.31% | 8.07% | -1.10% | Upgrade
|
| Cost of Revenue | 718.1 | 705.14 | 558.54 | 500.19 | 447.83 | 403.69 | Upgrade
|
| Gross Profit | 42.11 | 38.65 | 34.82 | 35.66 | 29.27 | 37.79 | Upgrade
|
| Selling, General & Admin | 25.68 | 25.36 | 20.62 | 22.13 | 19.47 | 27.58 | Upgrade
|
| Other Operating Expenses | -0.2 | -1.98 | 2.38 | 3.08 | 0.32 | 6.19 | Upgrade
|
| Operating Expenses | 27.71 | 26.01 | 28.06 | 29.23 | 21 | 34.87 | Upgrade
|
| Operating Income | 14.4 | 12.64 | 6.76 | 6.43 | 8.28 | 2.92 | Upgrade
|
| Interest Expense | -0.08 | -0.1 | -0.12 | -0.16 | -0.11 | -0.17 | Upgrade
|
| Interest & Investment Income | 1.3 | 1.25 | 0.94 | 0.47 | 0.16 | 0.09 | Upgrade
|
| Earnings From Equity Investments | -0.07 | -0.11 | -0.28 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.26 | -0.16 | -0.04 | -0.08 | -0.06 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.16 | 0.12 | 0.35 | 0.13 | -0.14 | 0.06 | Upgrade
|
| EBT Excluding Unusual Items | 15.45 | 13.65 | 7.6 | 6.79 | 8.13 | 2.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.45 | 0.45 | 1.31 | 0.27 | 0.51 | 39.9 | Upgrade
|
| Pretax Income | 15.9 | 14.09 | 8.91 | 7.06 | 8.63 | 42.77 | Upgrade
|
| Income Tax Expense | 7.38 | 7.13 | 1.71 | 1.25 | 1.4 | 5 | Upgrade
|
| Net Income | 8.52 | 6.96 | 7.2 | 5.81 | 7.23 | 37.77 | Upgrade
|
| Net Income to Common | 8.52 | 6.96 | 7.2 | 5.81 | 7.23 | 37.77 | Upgrade
|
| Net Income Growth | 28.28% | -3.33% | 23.97% | -19.69% | -80.85% | 1447.31% | Upgrade
|
| Shares Outstanding (Basic) | 96 | 96 | 96 | 96 | 95 | 106 | Upgrade
|
| Shares Outstanding (Diluted) | 96 | 96 | 96 | 96 | 95 | 106 | Upgrade
|
| Shares Change (YoY) | 0.13% | -0.01% | -0.03% | 0.13% | -10.06% | -0.03% | Upgrade
|
| EPS (Basic) | 0.09 | 0.07 | 0.08 | 0.06 | 0.08 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.09 | 0.07 | 0.08 | 0.06 | 0.08 | 0.36 | Upgrade
|
| EPS Growth | 28.12% | -3.32% | 24.01% | -19.79% | -78.71% | 1447.83% | Upgrade
|
| Free Cash Flow | 3.81 | 17.17 | 21.84 | -2.03 | 2.59 | -13.6 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.18 | 0.23 | -0.02 | 0.03 | -0.13 | Upgrade
|
| Dividend Per Share | 0.040 | 0.040 | 0.050 | 0.050 | 0.050 | 0.150 | Upgrade
|
| Dividend Growth | -20.00% | -20.00% | - | - | -66.67% | - | Upgrade
|
| Gross Margin | 5.54% | 5.20% | 5.87% | 6.65% | 6.14% | 8.56% | Upgrade
|
| Operating Margin | 1.89% | 1.70% | 1.14% | 1.20% | 1.74% | 0.66% | Upgrade
|
| Profit Margin | 1.12% | 0.94% | 1.21% | 1.08% | 1.52% | 8.56% | Upgrade
|
| Free Cash Flow Margin | 0.50% | 2.31% | 3.68% | -0.38% | 0.54% | -3.08% | Upgrade
|
| EBITDA | 15.92 | 14.56 | 10.89 | 10.45 | 9.14 | 3.44 | Upgrade
|
| EBITDA Margin | 2.09% | 1.96% | 1.84% | 1.95% | 1.92% | 0.78% | Upgrade
|
| D&A For EBITDA | 1.52 | 1.92 | 4.12 | 4.02 | 0.86 | 0.52 | Upgrade
|
| EBIT | 14.4 | 12.64 | 6.76 | 6.43 | 8.28 | 2.92 | Upgrade
|
| EBIT Margin | 1.89% | 1.70% | 1.14% | 1.20% | 1.74% | 0.66% | Upgrade
|
| Effective Tax Rate | 46.43% | 50.60% | 19.16% | 17.69% | 16.22% | 11.68% | Upgrade
|
| Revenue as Reported | 762.42 | 747.02 | 598.28 | 539.2 | 477.95 | 482.8 | Upgrade
|
| Advertising Expenses | - | 0.18 | 0.12 | 0.05 | 0.04 | 0.08 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.